A carregar...
Targeting FBPase is an emerging novel approach for cancer therapy
Cancer is a leading cause of death in both developed and developing countries. Metabolic reprogramming is an emerging hallmark of cancer. Glucose homeostasis is reciprocally controlled by the catabolic glycolysis and anabolic gluconeogenesis pathways. Previous studies have mainly focused on cataboli...
Na minha lista:
| Publicado no: | Cancer Cell Int |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845355/ https://ncbi.nlm.nih.gov/pubmed/29556139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0533-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|